XTANT MEDICAL HOLDINGS, INC. Business Acquisition, Pro Forma Net Income (Loss)
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Business Acquisition, Pro Forma Net Income (Loss) of $9.94 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2024-11-12
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was $21.51M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was -$5.61M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-06-30 was -$2.35M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-03-31 was -$3.61M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2023 was $9.94M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2022 was -$17.96M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2016 was -$19.49M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2015 was -$5.85M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $21.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $15.90M derived: sum of 2 quarters · filed 2024-11-12 | $13.55M derived: sum of 3 quarters · filed 2024-11-12 | $9.94M 10-K · filed 2024-04-01 | ||
| 2023-09-30 | -$5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$7.96M derived: sum of 2 quarters · filed 2024-11-12 | -$11.57M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$5.96M 10-Q · filed 2024-08-08 | -$3.75M 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | -$3.61M 10-Q · filed 2024-05-15 | -$1.59M 10-Q · filed 2023-05-04 | ||||
| 2022-12-31 | -$17.96M 10-K · filed 2024-04-01 | |||||
| 2022-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$2.54M 10-Q · filed 2023-08-01 | ||||
| 2022-03-31 | -$833.00K 10-Q · filed 2023-05-04 | |||||
| 2016-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$9.41M derived: sum of 2 quarters · filed 2017-03-29 | -$13.87M derived: sum of 3 quarters · filed 2017-03-29 | -$19.49M 10-K · filed 2017-03-29 | ||
| 2016-09-30 | -$4.90M 10-Q · filed 2016-11-10 | -$9.36M derived: sum of 2 quarters · filed 2016-11-10 | -$14.98M 10-Q · filed 2016-11-10 | -$4.74M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2016-06-30 | -$4.46M 10-Q · filed 2016-08-10 | -$10.06M 10-Q · filed 2016-08-10 | $157.33K derived: sum of 3 quarters · filed 2017-03-29 | -$5.20M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2016-03-31 | -$5.60M 10-Q · filed 2016-05-11 | $4.62M derived: sum of 2 quarters · filed 2017-03-29 | -$737.18K derived: sum of 3 quarters · filed 2017-03-29 | -$5.27M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2015-12-31 | $10.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $4.86M derived: sum of 2 quarters · filed 2017-03-29 | $325.06K derived: sum of 3 quarters · filed 2017-03-29 | -$5.85M 10-K · filed 2017-03-29 | ||
| 2015-09-30 | -$5.36M 10-Q · filed 2016-11-10 | -$9.89M derived: sum of 2 quarters · filed 2016-11-10 | -$16.06M 10-Q · filed 2016-11-10 | -$20.24M derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | -$4.53M 10-Q · filed 2016-08-10 | -$10.56M 10-Q · filed 2016-08-10 | -$14.88M derived: sum of 3 quarters · filed 2016-08-10 | -$17.65M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | -$6.03M 10-Q · filed 2016-05-11 | -$10.35M derived: sum of 2 quarters · filed 2016-05-11 | -$13.12M derived: sum of 3 quarters · filed 2016-05-11 | |||
| 2014-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | -$7.08M derived: sum of 2 quarters · filed 2016-03-24 | -$15.57M 10-K · filed 2016-03-24 | |||
| 2014-09-30 | -$2.77M 10-Q · filed 2015-11-16 | -$11.25M 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |